Biotricity, Inc.
BTCY
$0.25
$0.00-1.40%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.79% | -2.81% | 65.28% | -57.48% | 21.30% |
| Total Depreciation and Amortization | -47.25% | 15,026.67% | -99.64% | 289.94% | -47.25% |
| Total Amortization of Deferred Charges | -8.21% | 31.58% | -6.40% | -43.63% | -14.36% |
| Total Other Non-Cash Items | 297.09% | -171.93% | -91.21% | 2,010.28% | 200.98% |
| Change in Net Operating Assets | -166.93% | 7,636.00% | 101.79% | -183.20% | -3.42% |
| Cash from Operations | -278.13% | 211.30% | 6.84% | -354.94% | 77.81% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 169.54% | -32.43% | -11.16% | -30.30% | 14.17% |
| Total Debt Repaid | 87.17% | -- | -- | -15.44% | 50.24% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | 100.00% | -- | -- | -- | -- |
| Total Dividends Paid | 1.64% | -3.39% | 3.28% | -3.39% | 1.67% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 242.07% | -216.53% | 164.06% | -61.18% | -9.79% |
| Foreign Exchange rate Adjustments | -455.91% | 125.69% | -139.65% | 159.13% | -10,193.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.08% | -417.24% | 118.06% | -142.97% | 363.86% |